Literature DB >> 21961549

Chronic granulomatous herpes encephalitis: a rare entity posing a diagnostic challenge.

Matthew A Adamo1, Lisa Abraham, Ian F Pollack.   

Abstract

Herpesviruses can cause an acute, subacute, or chronic disease state in both immunocompetent and immunocompromised individuals. Herpes simplex virus (HSV) encephalitis is most often an acute monophasic disease process. Rarely, however, it may progress to a chronic state, and more rarely still to a granulomatous encephalitis. Prior studies have suggested that antiviral immunity with Toll-like receptors determines susceptibility to herpesviruses. The authors report the case of a 14-year-old girl with a remote history of treated HSV encephalitis, who had intractable seizures and worsening MR imaging changes that were concerning for either a neoplastic or an inflammatory process. She was found to have granulomatous herpes simplex encephalitis and had a low cytokine response to Toll-like receptor 3 stimulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21961549     DOI: 10.3171/2011.7.PEDS10393

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  3 in total

1.  Chronic herpes simplex type-1 encephalitis with intractable epilepsy in an immunosuppressed patient.

Authors:  Christopher Laohathai; Daniel J Weber; Ghazala Hayat; Florian P Thomas
Journal:  Infection       Date:  2015-07-18       Impact factor: 3.553

2.  A rare suspected case of chronic nodular granulomatous herpes simplex encephalitis in an adult.

Authors:  Lucy Childs; Guan Lim; Andrew Thompson; Timothy R Bates; Lay Kun Kho; Constantine Chris Phatouros
Journal:  BJR Case Rep       Date:  2018-03-14

3.  Chronic granulomatous herpes encephalitis in a child with clinically intractable epilepsy.

Authors:  James R Hackney; D Keith Harrison; Curtis Rozzelle; Suthida Kankirawatana; Pongkiat Kankirawatana; Cheryl Ann Palmer
Journal:  Case Rep Pediatr       Date:  2012-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.